American Vanguard 2025 Q3 Earnings 52.7% Loss Reduction and 350% EBITDA Surge

American Vanguard (AVD) reported mixed Q3 2025 results, with revenue and net income missing estimates but reaffirming full-year adjusted EBITDA guidance. , driven by cost-cutting and operational efficiency. CEO highlighted progress in debt reduction and market resilience ahead of 2026.

Revenue

, . U.S. Crop business performance was robust, with strength in herbicides and granular soil insecticides, while U.S. Non-Crop and International segments faced headwinds. U.S. , but U.S. . , impacted by strategic product discontinuations in Brazil and adverse weather in Australia and Central America.

Earnings/Net Income

, . . Despite a $7.6 million product liability charge, , driven by gross margin improvements and cost reductions. Despite a net loss, the significant EBITDA increase and loss narrowing indicate improved operational efficiency.

Post-Earnings Price Action Review

Following the earnings release, , , . .

CEO Commentary

, driven by cost reductions in working capital, factory costs, and operating expenses. He highlighted operational shifts, including relocating production to Alabama, . Kaye expressed confidence in the company’s resilience amid and trade tensions, prioritizing cash flow, debt reduction, and positioning for a market rebound.

Guidance

. . The company aims to maintain expense discipline, leverage low , .

Additional News

, expected to be recovered from a third-party formulator. . , emphasizing technological innovation. , .

Key Strategic Moves:

1. .

2. , with expected reimbursement.

3. .

Financial Priorities:

• .

• .

• .